Skip to main content
. 2021 May 20;10(10):2214. doi: 10.3390/jcm10102214

Table 2.

General data for the three categories.

Low Risk Intermediate Risk High Risk p-Value
N 352 3018 13,752
Age, median (IQR) 57.9 (43.7–71.3) 64.2 (51.7–76.5) 70.4 (57.8–80.3) <0.001
Gender (males) 132 (37.5) 1416 (46.9) 8264 (60.1) <0.001
Days from onset to admission, median (IQR) 6 (3–10) 7 (4–9) 6 (3–9) 0.005
Smoking behaviour <0.001
Never smoker 254 (72.2) 2201 (72.9) 9485 (69)
Former smoker 71 (20.2) 664 (22) 3582 (26)
Current smoker 27 (7.7) 153 (5.1) 685 (5)
Degree of dependency <0.001
None or mild 314 (89.2) 2595 (86) 11,423 (83.1)
Moderate 24 (6.8) 231 (7.7) 1329 (9.7)
Severe 14 (4) 192 (6.4) 1000 (7.3)
Arterial hypertension 130 (36.9) 1365 (45.2) 7260 (52.8) <0.001
Dyslipidemia 100 (28.4) 1118 (37) 5584 (40.6) <0.001
Diabetes mellitus 42 (11.9) 516 (17.1) 2822 (20.5) <0.001
Ischaemic cardiopathy 13 (3.7) 196 (6.5) 1151 (8.4) <0.001
Chronic heart failure 12 (3.4) 158 (5.2) 1045 (7.6) <0.001
Chronic liver disease 4 (1.1) 91 (3) 537 (3.9) 0.002
Severe chronic renal failure 8 (2.3) 108 (3.6) 920 (6.7) <0.001
Cancer 23 (6.5) 216 (7.2) 1521 (11.1) <0.001
COPD 20 (5.7) 163 (5.4) 972 (7.1) 0.003
Asthma 40 (11.4) 279 (9.2) 895 (7.1) <0.001
OSAS 16 (4.5) 188 (6.2) 839 (6.1) 0.455

IQR: interquartile range. COPD: chronic obstructive pulmonary disease. OSAS: obstructive sleep apnea syndrome. Severe chronic renal failure: Creatinin >300 mg/dL or dyalisis.